Disease Burden of Glaucoma in China: Findings from the Global Burden of Disease 2019 Study

Yi Sun,1,* Aiming Chen,2,* Minjie Zou,3,* Zhenzhen Liu,3 Charlotte Aimee Young,4 Danying Zheng,3 Guangming Jin3 1Department of Ophthalmology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, People’s Republic of China; 2The Fifth Affiliated Hospital of...

Full description

Bibliographic Details
Main Authors: Sun Y, Chen A, Zou M, Liu Z, Young CA, Zheng D, Jin G
Format: Article
Language:English
Published: Dove Medical Press 2022-07-01
Series:Clinical Epidemiology
Subjects:
Online Access:https://www.dovepress.com/disease-burden-of-glaucoma-in-china-findings-from-the-global-burden-of-peer-reviewed-fulltext-article-CLEP
_version_ 1818116036722950144
author Sun Y
Chen A
Zou M
Liu Z
Young CA
Zheng D
Jin G
author_facet Sun Y
Chen A
Zou M
Liu Z
Young CA
Zheng D
Jin G
author_sort Sun Y
collection DOAJ
description Yi Sun,1,* Aiming Chen,2,* Minjie Zou,3,* Zhenzhen Liu,3 Charlotte Aimee Young,4 Danying Zheng,3 Guangming Jin3 1Department of Ophthalmology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, People’s Republic of China; 2The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, People’s Republic of China; 3State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, 510060, People’s Republic of China; 4Department of Ophthalmology, Third Affiliated Hospital, Nanchang University, Nanchang, Jiangxi Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Guangming Jin; Danying Zheng, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, #54 Xianlie South Road, Yuexiu District, Guangzhou, 510060, People’s Republic of China, Email jingm@mail2.sysu.edu.cn; zhengdyy@163.comPurpose: To provide evidence for future strategies in preventing glaucomatous blindness by investigating the disease burden in terms of age, year, and gender from 1990 to 2019 in China.Methods: The prevalence and disability-adjusted life years (DALYs) of blindness and vision loss due to glaucoma in China were extracted from the Global Burden of Disease (GBD) 2019 study. Age-standardized data is presented in comparison to China’s neighboring countries.Results: From 1990 to 2019, the prevalent cases and DALYs number with glaucomatous blindness and vision loss increased by 129.53% and 67.29%, respectively. Overall, higher age-standardized prevalence and DALYs rate were detected in males than in females between 1990 and 2019, and people aged 60 to 89 years suffered from a higher DALY number than other age groups in 2019. Among the neighboring countries, China ranked from fourth in 1990 (88.52, 95% uncertainty interval [UI]: 74.62 to 103.24, per 100,000 population) to third in 2019 (71.14, 95% UI: 59.34 to 84.42, per 100,000 population) in age-standardized prevalence while from fourth in 1990 (10.13, 95% UI: 6.68 to 14.46, per 100,000 population) to sixth in 2019 (5.98, 95% UI: 4.14 to 8.42, per 100,000 population) in age-standardized DALYs. Compared with other GBD regions, the largest decrease in age-standardized DALY rate due to glaucoma was found in China (− 40.87%, 95% UI: − 43.97% to − 37.82%). A higher percentage decrease in age-standardized prevalence was also found in China (− 19.66%, 95% UI: − 22.44% to − 17.09%).Conclusion: Substantial increases in the prevalence of visual impairment and DALYs number of glaucoma were observed from 1990 to 2019. Efforts targeting glaucoma prevention and treatment in China are urgently required, especially for the elderly population and men.Keywords: glaucoma, epidemiology, disability-adjusted life years, health burden
first_indexed 2024-12-11T04:16:08Z
format Article
id doaj.art-2e3703092f204786bfcde10f3ee967de
institution Directory Open Access Journal
issn 1179-1349
language English
last_indexed 2024-12-11T04:16:08Z
publishDate 2022-07-01
publisher Dove Medical Press
record_format Article
series Clinical Epidemiology
spelling doaj.art-2e3703092f204786bfcde10f3ee967de2022-12-22T01:21:14ZengDove Medical PressClinical Epidemiology1179-13492022-07-01Volume 1482783476353Disease Burden of Glaucoma in China: Findings from the Global Burden of Disease 2019 StudySun YChen AZou MLiu ZYoung CAZheng DJin GYi Sun,1,* Aiming Chen,2,* Minjie Zou,3,* Zhenzhen Liu,3 Charlotte Aimee Young,4 Danying Zheng,3 Guangming Jin3 1Department of Ophthalmology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, People’s Republic of China; 2The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, People’s Republic of China; 3State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, 510060, People’s Republic of China; 4Department of Ophthalmology, Third Affiliated Hospital, Nanchang University, Nanchang, Jiangxi Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Guangming Jin; Danying Zheng, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, #54 Xianlie South Road, Yuexiu District, Guangzhou, 510060, People’s Republic of China, Email jingm@mail2.sysu.edu.cn; zhengdyy@163.comPurpose: To provide evidence for future strategies in preventing glaucomatous blindness by investigating the disease burden in terms of age, year, and gender from 1990 to 2019 in China.Methods: The prevalence and disability-adjusted life years (DALYs) of blindness and vision loss due to glaucoma in China were extracted from the Global Burden of Disease (GBD) 2019 study. Age-standardized data is presented in comparison to China’s neighboring countries.Results: From 1990 to 2019, the prevalent cases and DALYs number with glaucomatous blindness and vision loss increased by 129.53% and 67.29%, respectively. Overall, higher age-standardized prevalence and DALYs rate were detected in males than in females between 1990 and 2019, and people aged 60 to 89 years suffered from a higher DALY number than other age groups in 2019. Among the neighboring countries, China ranked from fourth in 1990 (88.52, 95% uncertainty interval [UI]: 74.62 to 103.24, per 100,000 population) to third in 2019 (71.14, 95% UI: 59.34 to 84.42, per 100,000 population) in age-standardized prevalence while from fourth in 1990 (10.13, 95% UI: 6.68 to 14.46, per 100,000 population) to sixth in 2019 (5.98, 95% UI: 4.14 to 8.42, per 100,000 population) in age-standardized DALYs. Compared with other GBD regions, the largest decrease in age-standardized DALY rate due to glaucoma was found in China (− 40.87%, 95% UI: − 43.97% to − 37.82%). A higher percentage decrease in age-standardized prevalence was also found in China (− 19.66%, 95% UI: − 22.44% to − 17.09%).Conclusion: Substantial increases in the prevalence of visual impairment and DALYs number of glaucoma were observed from 1990 to 2019. Efforts targeting glaucoma prevention and treatment in China are urgently required, especially for the elderly population and men.Keywords: glaucoma, epidemiology, disability-adjusted life years, health burdenhttps://www.dovepress.com/disease-burden-of-glaucoma-in-china-findings-from-the-global-burden-of-peer-reviewed-fulltext-article-CLEPglaucomaepidemiologydisability-adjusted life yearshealth burden
spellingShingle Sun Y
Chen A
Zou M
Liu Z
Young CA
Zheng D
Jin G
Disease Burden of Glaucoma in China: Findings from the Global Burden of Disease 2019 Study
Clinical Epidemiology
glaucoma
epidemiology
disability-adjusted life years
health burden
title Disease Burden of Glaucoma in China: Findings from the Global Burden of Disease 2019 Study
title_full Disease Burden of Glaucoma in China: Findings from the Global Burden of Disease 2019 Study
title_fullStr Disease Burden of Glaucoma in China: Findings from the Global Burden of Disease 2019 Study
title_full_unstemmed Disease Burden of Glaucoma in China: Findings from the Global Burden of Disease 2019 Study
title_short Disease Burden of Glaucoma in China: Findings from the Global Burden of Disease 2019 Study
title_sort disease burden of glaucoma in china findings from the global burden of disease 2019 study
topic glaucoma
epidemiology
disability-adjusted life years
health burden
url https://www.dovepress.com/disease-burden-of-glaucoma-in-china-findings-from-the-global-burden-of-peer-reviewed-fulltext-article-CLEP
work_keys_str_mv AT suny diseaseburdenofglaucomainchinafindingsfromtheglobalburdenofdisease2019study
AT chena diseaseburdenofglaucomainchinafindingsfromtheglobalburdenofdisease2019study
AT zoum diseaseburdenofglaucomainchinafindingsfromtheglobalburdenofdisease2019study
AT liuz diseaseburdenofglaucomainchinafindingsfromtheglobalburdenofdisease2019study
AT youngca diseaseburdenofglaucomainchinafindingsfromtheglobalburdenofdisease2019study
AT zhengd diseaseburdenofglaucomainchinafindingsfromtheglobalburdenofdisease2019study
AT jing diseaseburdenofglaucomainchinafindingsfromtheglobalburdenofdisease2019study